يعرض 11 - 20 نتائج من 658 نتيجة بحث عن '"MTOR Inhibitors"', وقت الاستعلام: 0.81s تنقيح النتائج
  1. 11
    دورية
    Researchers at Northwestern University Feinberg School of Medicine Release New Study Findings on Thyroid Cancer (Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly...).

    المصدر: Immunotherapy Weekly; 2/15/2024, p956-956, 1p

    مصطلحات موضوعية: MTOR inhibitors, IPILIMUMAB, NIVOLUMAB, THYROID cancer, RESEARCH personnel, DRUGS

    الشركة/الكيان: NORTHWESTERN University (Evanston, Ill.)


    أضف إلى المفضلة
  2. 12
    دورية
    Findings from Mazandaran University of Medical Sciences in the Area of Acute Myeloid Leukemia Reported (Glucose Metabolism In Acute Myeloid Leukemia Cell Line Is Regulated Via Combinational Pi3k/akt/mtor Pathway Inhibitors).

    المصدر: Drug Week; 2/16/2024, p668-668, 1p

    مصطلحات موضوعية: ACUTE myeloid leukemia, MYELOID cells, GLUCOSE metabolism, MTOR inhibitors, CELL lines, GLUCOSE transporters, PYRUVATES


    أضف إلى المفضلة
  3. 13
    دورية
    "Methods Of Treating Colon Cancer Using Nanoparticle Mtor Inhibitor Combination Therapy" in Patent Application Approval Process (USPTO 20240009323).

    المصدر: Women's Health Weekly; 2/2/2024, p1283-1283, 1p

    مصطلحات موضوعية: MTOR inhibitors, EVEROLIMUS, PATENT applications, COLON cancer, NANOPARTICLES, VASCULAR endothelial growth factors


    أضف إلى المفضلة
  4. 14
    Immune checkpoint blockade for organ-transplant recipients with cancer: A review

    المؤلفون: Alessandra Rünger, Dirk Schadendorf, Axel Hauschild, Christoffer Gebhardt

    المصدر: European Journal of Cancer. 175:326-335

    مصطلحات موضوعية: Graft Rejection, Cancer Research, Oncology, Neoplasms, TOR Serine-Threonine Kinases, Humans, MTOR Inhibitors, Immune Checkpoint Inhibitors, Immunosuppressive Agents, Transplant Recipients

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e000161ab5212e7067d5282e0682761Test
    https://doi.org/10.1016/j.ejca.2022.08.010Test


    أضف إلى المفضلة
  5. 15
    دورية أكاديمية
    A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing ... : نهج متعدد الأهداف لاكتشاف عوامل السرطان المضادة لساركوما العظم من خلال إعادة استخدام الأدوية ...

    المؤلفون: Alejandro Cabrera‐Andrade, Andrés López‐Cortés, Gabriela Jaramillo-Koupermann, Humberto González-Dı́az, Alejandro Pazos, Cristian R. Munteanu, Yunierkis Pérez‐Castillo, Eduardo Tejera

    مصطلحات موضوعية: Targeted Protein Degradation in Biomedical Research, Molecular Biology, Biochemistry, Genetics and Molecular Biology, Life Sciences, Computational Methods in Drug Discovery, Computational Theory and Mathematics, Computer Science, Physical Sciences, Protein Arginine Methylation in Mammals, Drug Target Identification, Drug Discovery Paradigm, Osteosarcoma, DrugBank, Drug repositioning, Medicine, Temsirolimus, chEMBL, Paclitaxel, Cancer, Cabazitaxel, Oncology, Drug, Pharmacology, Drug discovery, Internal medicine, Bioinformatics, FOS Computer and information sciences, Prostate cancer, Cancer research, Discovery and development of mTOR inhibitors

    العلاقة: https://dx.doi.org/10.60692/ctz4q-43g38Test

    الإتاحة: https://doi.org/10.60692/ms2df-re13810.60692/ctz4q-43g38Test

    View record in BASE

    أضف إلى المفضلة
  6. 16
    دورية
    Investigators at Johns Hopkins University Report Findings in Kidney Cancer ("oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent Tsc-mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas: Association With Prior Childhood...).

    المصدر: Drug Week; 1/5/2024, p418-418, 1p

    مصطلحات موضوعية: RENAL cell carcinoma, RENAL cancer, NEUROBLASTOMA, CHILDHOOD cancer, MTOR inhibitors

    مصطلحات جغرافية: BALTIMORE (Md.)

    الشركة/الكيان: JOHNS Hopkins University


    أضف إلى المفضلة
  7. 17
    دورية أكاديمية
    MEK inhibition overcomes everolimus resistance in gastric cancer.

    المؤلفون: Liu, Hongfang, Yao, Yang, Zhang, Juan, Li, Jing

    المصدر: Cancer Chemotherapy & Pharmacology; Jun2020, Vol. 85 Issue 6, p1079-1087, 9p

    مصطلحات موضوعية: STOMACH cancer, EXTRACELLULAR signal-regulated kinases, BCL-2 proteins, MTOR inhibitors, CELL culture, ONCOLOGY


    أضف إلى المفضلة
  8. 18
    دورية
    New Mesotheliomas Study Findings Recently Were Reported by a Researcher at National Center for Advancing Translational Sciences (Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo...).

    المصدر: Cancer Weekly; 12/12/2023, p600-600, 1p

    مصطلحات موضوعية: RESEARCH personnel, MTOR inhibitors, DRUG development, MESOTHELIOMA, DRUG therapy


    أضف إلى المفضلة
  9. 19
    دورية
    Enhancing CAR-T Cell Metabolism to Overcome Hypoxic Conditions in the Brain Tumor Microenvironment.

    المصدر: Clinical Oncology Week; 11/28/2023, p290-290, 1p

    مصطلحات موضوعية: BRAIN tumors, TUMOR microenvironment, CELL metabolism, CHIMERIC antigen receptors, AMP-activated protein kinases, MTOR inhibitors


    أضف إلى المفضلة
  10. 20
    دورية أكاديمية
    A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.

    المؤلفون: Wolin, Edward, Mita, Alain, Mahipal, Amit, Meyer, Tim, Bendell, Johanna, Nemunaitis, John, Munster, Pam N., Paz-Ares, Luis, Filvaroff, Ellen H., Li, Shaoyi, Hege, Kristen, de Haan, Hans, Mita, Monica

    المصدر: PLoS ONE; 9/17/2019, Vol. 14 Issue 9, p1-14, 14p

    مصطلحات موضوعية: IRINOTECAN, NEUROENDOCRINE tumors, CARCINOID, KINASE inhibitors, PROGRESSION-free survival, MTOR inhibitors, AUTOPHAGY, EOSINOPHILIA

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث